Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 30 Similar Profiles
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Radiation Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Neck Medicine & Life Sciences
Practice Guidelines Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1989 2019

Research Output 1988 2017

  • 7246 Citations
  • 36 Scopus h-Index
  • 102 Article
  • 24 Review article
  • 1 Editorial

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

Samuels, S. E., Stenmark, M. H., Lee, J. Y., McHugh, J. B., Hayman, J. A., Orringer, M. B., Urba, S. G., Sun, L., Xie, C., Kong, F. M. & Cuneo, K. C. 2017 In : Advances in Radiation Oncology.

Research output: Contribution to journalArticle

Chemoradiotherapy
Esophageal Neoplasms
Mortality
Esophagectomy
Confidence Intervals

Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs)

Ronellenfitsch, U., Schwarzbach, M., Hofheinz, R., Kienle, P., Nowak, K., Kieser, M., Slanger, T. E., Burmeister, B., Kelsen, D., Niedzwiecki, D., Schuhmacher, C., Urba, S., van de Velde, C., Walsh, T. N., Ychou, M. & Jensen, K. Aug 1 2017 In : European Journal of Surgical Oncology. 43, 8, p. 1550-1558 9 p.

Research output: Contribution to journalArticle

Adenocarcinoma
Randomized Controlled Trials
Recurrence
Drug Therapy
Neoadjuvant Therapy

Survival rates using individualized bioselection treatment methods in patients with advanced laryngeal cancer

Wolf, G. T., Bellile, E., Eisbruch, A., Urba, S., Bradford, C. R., Peterson, L., Prince, M. E., Teknos, T. N., Chepeha, D. B., Hogikyan, N. D., McLean, S. A., Moyer, J., Taylor, J. M. G. & Worden, F. P. Apr 1 2017 In : JAMA Otolaryngology - Head and Neck Surgery. 143, 4, p. 355-366 12 p.

Research output: Contribution to journalArticle

Laryngeal Neoplasms
Survival Rate
Chemoradiotherapy
Drug Therapy
Radiotherapy
1 Citations

A phase II biomarker-embedded study of lapatinib plus capecitabine as first-line therapy in patients with advanced or metastatic gastric cancer

LaBonte, M. J., Yang, D., Zhang, W., Wilson, P. M., Nagarwala, Y. M., Koch, K. M., Briner, C., Kaneko, T., Rha, S. Y., Gladkov, O., Urba, S. G., Sakaeva, D., Pishvaian, M. J., Hsieh, R. K., Lee, W. P. & Lenz, H. J. Sep 1 2016 In : Molecular Cancer Therapeutics. 15, 9, p. 2251-2258 8 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Stomach Neoplasms
Biological Markers
Esophagogastric Junction
Single Nucleotide Polymorphism
Genetic Suppression
Laryngeal Neoplasms
Neoplasms
Cyclin D1
Mutation